Aspira Women’s Health (AWH) has released an update to notify the public and investors about the unregistered sales of equity securities.
The securities issued in the concurrent private placement are unregistered and are offered under an exemption according to Section 4(a)(2) of the Securities Act and Rule 506(b). This information is incorporated from Item 1.01 into Item 3.02.
For further insights into AWH stock, check out TipRanks’ Stock Analysis page.
